Trade in substandard and falsified medicines
According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical capacity and poor governance contribute to th...
| 主要な著者: | , , |
|---|---|
| その他の著者: | |
| フォーマット: | Book section |
| 言語: | English |
| 出版事項: |
Nomos
2022
|